Chloroquine and COVID-19, where do we stand?
作者信息
Lecuit M
机构信息
Institut Pasteur, Biology of Infection Unit, 75015 Paris, France; Inserm U1117, 75015 Paris, France; Université de Paris, Necker-Enfants Malades University Hospital, Division of Infectious Diseases and Tropical Medicine; Institut Imagine; APHP, 75006 Paris, France.
出版信息
Med Mal Infect. 2020 May;50(3):229-230. doi: 10.1016/j.medmal.2020.03.004. Epub 2020 Mar 27.
Abstract
摘要
相似文献
1
Chloroquine and COVID-19, where do we stand?氯喹与新型冠状病毒肺炎，我们目前的情况如何？
Med Mal Infect. 2020 May;50(3):229-230. doi: 10.1016/j.medmal.2020.03.004. Epub 2020 Mar 27.
2
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
3
[Chloroquine as a possible treatment for COVID-19].[氯喹作为新型冠状病毒肺炎的一种可能治疗方法]
Ned Tijdschr Geneeskd. 2020 Mar 11;164:D4936.
4
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
5
Regulators split on antimalarials for COVID-19.监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
6
Treating COVID-19 with Chloroquine.用氯喹治疗新型冠状病毒肺炎。
J Mol Cell Biol. 2020 May 18;12(4):322-325. doi: 10.1093/jmcb/mjaa014.
7
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.用于治疗新冠肺炎的氯喹/羟氯喹引发室性心律失常的风险：是否应该使用该药？
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
8
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
9
[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].[羟氯喹和氯喹治疗新冠病毒病：无有效性证据]
Ned Tijdschr Geneeskd. 2020 Jun 2;164:D5141.
10
COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.新型冠状病毒肺炎与抗疟药物：弊大于利
Am J Crit Care. 2020 Nov 1;29(6):489-492. doi: 10.4037/ajcc2020694.
引用本文的文献
1
Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges.2019冠状病毒病大流行期间哮喘患者的管理：应对挑战的病理生理学考量
Beni Suef Univ J Basic Appl Sci. 2022;11(1):20. doi: 10.1186/s43088-022-00204-4. Epub 2022 Feb 5.
2
Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria.以阿尔及利亚为例，回顾抗击新冠疫情中一种有争议的治疗方法。
Bull Natl Res Cent. 2021;45(1):94. doi: 10.1186/s42269-021-00550-w. Epub 2021 May 20.
3
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.2019年冠状病毒病的治疗方式与机制
Front Pharmacol. 2021 Feb 8;11:583914. doi: 10.3389/fphar.2020.583914. eCollection 2020.
4
First principle simulation of coated hydroxychloroquine on Ag, Au and Pt nanoparticles.基于第一性原理对负载有羟氯喹的 Ag、Au 和 Pt 纳米粒子的模拟。
Sci Rep. 2021 Jan 22;11(1):2131. doi: 10.1038/s41598-021-81617-6.
5
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin.新型冠状病毒肺炎、肺结核和人类免疫缺陷病毒的罕见关联，在氯喹和利福平治疗下病情进展良好。
Pan Afr Med J. 2020 Jul 13;35(Suppl 2):110. doi: 10.11604/pamj.supp.2020.35.2.24952. eCollection 2020.
6
Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.兴衰：羟氯喹与新冠疫情全球趋势：关注度、政治影响及潜在影响
ACR Open Rheumatol. 2020 Dec;2(12):760-766. doi: 10.1002/acr2.11207. Epub 2020 Dec 2.
7
DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19.氯喹衍生物作为抗冠状病毒COVID-19的抗病毒药物的密度泛函理论（DFT）和分子对接研究
J King Saud Univ Sci. 2021 Jan;33(1):101248. doi: 10.1016/j.jksus.2020.101248. Epub 2020 Nov 25.
8
Quantum mechanical simulation of Chloroquine drug interaction with C60 fullerene for treatment of COVID-19.用于治疗新冠肺炎的氯喹药物与C60富勒烯相互作用的量子力学模拟
Chem Phys Lett. 2020 Oct 16;757:137869. doi: 10.1016/j.cplett.2020.137869. Epub 2020 Aug 9.
9
Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19.关于重新定位氯喹和羟氯喹用于治疗新冠病毒病的观点。
Sudan J Paediatr. 2020;20(1):4-9. doi: 10.24911/SJP.106-1587122398.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.羟氯喹啉是氯喹毒性较低的衍生物，在体外可有效抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
3
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
4
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
5
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
6
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
Zotero 插件